Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK GITTE OG TROELS GAARDE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   0.8% 1.0% 0.8% 0.7% 1.1% 0.6% 7.6% 7.6%   Credit score (0-100)   92 89 91 95 85 95 32 32   Credit rating   AA A AA AA A AA BB BB   Credit limit (kDKK)   1,101.3 1,095.7 1,759.6 2,038.5 908.5 2,132.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -10.9 -220 -188 -230 -286 -177 0.0 0.0   EBITDA   -2,378 -2,172 -1,547 -1,703 -1,970 -1,345 0.0 0.0   EBIT   -2,447 -2,257 -1,632 -1,788 -2,055 -1,373 0.0 0.0   Pre-tax profit (PTP)   738.1 5,932.5 1,557.1 4,120.4 -844.9 3,659.9 0.0 0.0   Net earnings   572.7 4,705.1 1,271.8 3,275.1 -581.2 2,916.8 0.0 0.0   Pre-tax profit without non-rec. items   738 5,933 1,557 4,120 -845 3,660 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   368 283 198 113 28.3 0.0 0.0 0.0   Shareholders equity total   14,032 18,337 19,498 22,173 20,412 22,828 19,764 19,764   Interest-bearing liabilities   64.8 9.7 92.0 77.0 246 0.0 0.0 0.0   Balance sheet total (assets)   14,511 19,396 20,799 23,004 21,095 23,352 19,764 19,764   Net Debt   -8,937 -14,307 -15,923 -18,283 -15,962 -19,124 -19,764 -19,764     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -10.9 -220 -188 -230 -286 -177 0.0 0.0   Gross profit growth   0.0% -1,917.5% 14.5% -22.5% -24.2% 38.0% 0.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   14,511 19,396 20,799 23,004 21,095 23,352 19,764 19,764   Balance sheet change%   2.6% 33.7% 7.2% 10.6% -8.3% 10.7% -15.4% 0.0%   Added value   -2,377.6 -2,172.2 -1,547.3 -1,702.9 -1,969.7 -1,345.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   259 -170 -170 -170 -170 -57 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22,455.2% 1,026.5% 868.3% 776.5% 718.5% 774.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.6% 35.1% 7.9% 19.0% 4.2% 16.5% 0.0% 0.0%   ROI %   9.9% 36.5% 8.3% 19.9% 4.3% 16.9% 0.0% 0.0%   ROE %   4.2% 29.1% 6.7% 15.7% -2.7% 13.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   96.7% 94.5% 93.7% 96.4% 96.8% 97.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   375.9% 658.6% 1,029.1% 1,073.6% 810.4% 1,421.8% 0.0% 0.0%   Gearing %   0.5% 0.1% 0.5% 0.3% 1.2% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1,954.3% 36.7% 43.5% 50.2% 1,099.8% 10.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   25.9 18.2 14.7 25.2 27.1 39.6 0.0 0.0   Current Ratio   25.9 18.2 14.7 25.2 27.1 39.6 0.0 0.0   Cash and cash equivalent   9,002.2 14,316.6 16,014.6 18,359.7 16,208.2 19,123.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,747.2 2,336.3 6,265.1 2,359.7 1,804.1 1,805.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -1,189 -1,086 -774 -851 -985 -673 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -1,189 -1,086 -774 -851 -985 -673 0 0   EBIT / employee   -1,224 -1,129 -816 -894 -1,027 -687 0 0   Net earnings / employee   286 2,353 636 1,638 -291 1,458 0 0